← Insider buys
CNCE

Concert Pharmaceuticals, Inc.

Bvf Partners L P/il sold $34.2M of Concert Pharmaceuticals, Inc.

10% owner

Sold$34,188,112
$26.65Price
1,282,856Shares
−91%Stake

What CNCE did after the filing

Prices for CNCE after this filing aren't in yet.

Traded Tue, Dec 19. Filed Thu, Dec 21, 2:40 PM ET, during the session. Not investment advice.